WILMETTE, Ill., April 16, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer patients, today ...

Joe Lally (left) and Temple Keller are intellectual property attorneys in the Austin office of Jackson Walker LLP. (Courtesy photos) Most rejections issued by patent examiners at the U.S. Patent and ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vistagen (NASDAQ: VTGN) a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, ...

Vistagen (Nasdaq: VTGN), a clinical-stage biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals affected by psychiatric and neurological disorders, ...

A pair of 2018 decisions from the Federal Circuit have resulted in the deferral of many patent eligibility issues through summary judgment and even to jury trials. Practitioners confronted with ...

Counsel at Capital One, Wells Fargo and the Clearing House Payments Company say they file patents when there is an appropriate business case and only look at patent eligibility requirements as a ...

“The district court concluded that the ’327 Patent was directed to the abstract idea of placing an item at an intermediate location before moving it to a final one in order to increase the accuracy of ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

—European Patent Office Grants New Patent Covering Use of CM-101 for the Treatment of Multiple Liver Diseases including Primary Sclerosing Cholangitis— —Further Extends Protections Afforded by CM-101 ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Vistagen (Nasdaq: VTGN), a clinical-stage biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals affected ...